|
DGCRF
|
Once we get past this seller, who has been here for some time, we will hit $1...
|
|
DGCRF
|
I agree with you 100%, GPRO has an offer in mind but is unable to move...
|
|
DGCRF
|
Share price should be over $1.00 today. Small market sell orders continue to...
|
|
DGCRF
|
I noticed that the news came out on the FDA site on Sunday night. Surprised...
|
|
DGCRF
|
http://www.webmd.com/prostate-cancer/news/20110803/urine-test-may-help...
|
|
DGCRF
|
web MD just released news of a pca3 study just completed and published on...
|
|
DGCRF
|
http://www.post-journal.com/
under local stories 3rd one down
|
|
DGCRF
|
Dr. Walter expresses a profound interest in his specialty; cancer of the...
|
|
DGCRF
|
the FDA has confirmed the date for a meeting of their immunology advisory...
|
|
DGCRF
|
Could someone post market depth. Thanks in advance.
|
|
DGCRF
|
Its nice to see the news start to flow. Should help to boost investor...
|
|
DGCRF
|
I'm surprised at how the stock has traded today given that we were one of...
|
|
DGCRF
|
63,000 shares traded yesterday in the U.S. and I think only 15,000 shares...
|
|
DGCRF
|
This news extends CUR's agreement til 2027 with Gen-Probe. This even...
|
|
DGCRF
|
Great to see some news. I have had a couple calls about what I meant in terms...
|
|
DGCRF
|
Its easy to see by the # of hits that that these posts are getting that...
|
|
DGCRF
|
There really is at least 1 new study that comes out every few weeks that is...
|
|
DGCRF
|
Currently several key U.S. hospitals are using PCA3 as a screening tool along...
|
|
DGCRF
|
Interesting because all of the abstracts that have anything to do with...
|
|
DGCRF
|
Gen-Probe is a hot company from what I am reading and what makes them so...
|